C20ORF118 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11022302462516E-16 |
Normal-vs-Stage2 |
1.0084999502169E-10 |
Normal-vs-Stage3 |
2.10131911870803E-12 |
Normal-vs-Stage4 |
2.09320005772895E-10 |
Stage1-vs-Stage2 |
3.248600E-01 |
Stage1-vs-Stage3 |
1.232390E-01 |
Stage1-vs-Stage4 |
6.194100E-02 |
Stage2-vs-Stage3 |
8.049600E-01 |
Stage2-vs-Stage4 |
6.068200E-01 |
Stage3-vs-Stage4 |
7.476800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
2.55018228756398E-12 |
Normal-vs-Asian |
5.933200E-01 |
Caucasian-vs-AfricanAmerican |
9.134400E-01 |
Caucasian-vs-Asian |
3.399400E-03 |
AfricanAmerican-vs-Asian |
1.441270E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
6.771400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.218100E-03 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.78119999971749E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.463800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.210770E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.444800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.625750E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.250600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.152800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.98140000038516E-07 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62803104331033E-12 |
Normal-vs-Grade 4 |
4.38119995838093E-09 |
Grade 1-vs-Grade 2 |
7.909600E-01 |
Grade 1-vs-Grade 3 |
3.222000E-01 |
Grade 1-vs-Grade 4 |
1.330160E-01 |
Grade 2-vs-Grade 3 |
2.677700E-02 |
Grade 2-vs-Grade 4 |
6.928300E-02 |
Grade 3-vs-Grade 4 |
6.703000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
4.38340030939344E-10 |
ccA subtype-vs-ccB subtype |
2.41759999999314E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62680979798324E-12 |
Normal-vs-N1 |
2.573600E-01 |
N0-vs-N1 |
1.101960E-01 |
|
|